Effects of electroacupuncture at 2 and 100 Hz on rat type 2 diabetic neuropathic pain and hyperalgesia-related protein expression in the dorsal root ganglion

J Zhejiang Univ Sci B. 2017;18(3):239-248. doi: 10.1631/jzus.B1600247.

Abstract

Objective: To investigate the analgesic effects of electroacupuncture (EA) at 2 and 100 Hz on type 2 diabetic neuropathic pain (DNP) and on the expressions of the P2X3 receptor and calcitonin gene-related peptide (CGRP) in the dorsal root ganglion (DRG).

Methods: Rat type 2 DNP was induced by a high calorie and high sugar diet fed for 7 weeks, plus a single intraperitoneal injection of streptozotocin (STZ) after 5 weeks. EA at 2 and 100 Hz was carried out once every day after 7 weeks for 7 consecutive days. Body weight, serum fasting insulin (FINS), fasting blood glucose (FBG), insulin sensitivity index (ISI), and paw withdrawal latency (PWL) were measured. The expressions of L4-L6 DRG P2X3 receptors and CGRP were assessed by immunofluorescence.

Results: Type 2 DNP was successfully induced as shown by the increased body weight, FINS, and FBG, as well as the reduced ISI and PWL. Expressions of P2X3 receptors and CGRP in L4-L6 DRGs increased. EA at both 2 and 100 Hz relieved type 2 DNP, but the analgesic effect of EA was stronger at 2 Hz. P2X3 receptor expression decreased in L4-L6 DRGs following EA at 2 Hz and in L5 and L6 DRGs following EA at 100 Hz. EA at both 2 and 100 Hz down-regulated CGRP overexpression in L4-L6 DRGs.

Conclusions: These findings indicate that EA at 2 Hz is a good option for the management of type 2 DNP. The EA effect may be related to its down-regulation of the overexpressions of the DRG P2X3 receptors and CGRP in this condition.

Keywords: Calcitonin gene-related peptide; Dorsal root ganglion; Electroacupuncture; P2X3 receptor; Type 2 diabetic neuropathic pain.

MeSH terms

  • Animals
  • Body Weight
  • Calcitonin Gene-Related Peptide / metabolism
  • Diabetes Mellitus, Type 2 / therapy*
  • Electroacupuncture / methods*
  • Ganglia, Spinal / physiology*
  • Hyperalgesia / physiopathology
  • Hyperalgesia / therapy*
  • Male
  • Neuralgia / therapy*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P2X3 / metabolism
  • Treatment Outcome
  • Up-Regulation

Substances

  • Receptors, Purinergic P2X3
  • Calcitonin Gene-Related Peptide